丹参注射液联合尼卡地平治疗妊娠期高血压的临床效果
来源:用户上传
作者:
[摘要]目的 探討丹参注射液联合尼卡地平治疗妊娠期高血压(GH)的临床效果,旨在为临床更好的治疗GH提供依据。方法 选取2016年6月~2017年12月我院收治的120例GH孕妇作为研究对象,根据随机数字表法分为对照组和治疗组,每组各60例。对照组采用一般治疗手段,口服尼卡地平缓释胶囊,服药方法2次/d,每次40 mg;治疗组在对照组的给药基础上额外给予静脉滴注丹参注射液;两组均治疗14 d,比较血压、凝血时间、血脂水平、妊娠结局等评价指标。结果 治疗组的治疗总有效率高于对照组,差异有统计学意义(P<0.05);治疗组治疗后的凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)高于对照组,收缩压(SBP)、舒张压(DBP)及低密度脂蛋白(LDL-C)/高密度脂蛋白(HDL-C)低于对照组,差异有统计学意义(P<0.05);治疗组产后24 h出血量少于对照组,1 min Apgar评分高于对照组,差异有统计学意义(P<0.05)。结论 使用丹参注射液联合尼卡地平可降低GH孕妇的高血压情况,调节凝血功能和血脂代谢,保护胎盘功能,改善母婴妊娠结局。
[关键词]丹参注射液;盐酸尼卡地平缓释胶囊;妊娠期高血压;母婴结局
[中图分类号] R714.246 [文献标识码] A [文章编号] 1674-4721(2019)8(a)-0129-03
[Abstract] Objective To explore the clinical effect of Danshen Injection combined with Nicardipine in the treatment of hypertensive disorder complicating pregnancy (GH), so as to provide basis for better clinical treatment of GH. Methods 120 patients with GH admitted to our hospital from June 2016 to December 2017 were selected as the research object and divided into control group and treatment group according to the random number table method, 60 cases in each group. The control group took Nicardipine Sustained-Release Capsules orally with the usual treatment method of 40 mg, twice a day. The treatment group was additionally given Danshen Injection on the basis of the control group. Both groups were treated for 14 days, and blood pressure, coagulation time, blood lipid level and pregnancy outcome were compared. Results The total effective rate of treatment group was higher than that of control group, the difference was statistically significant (P<0.05). The prothrombin time (PT) and activated partial thromboplastin time (APTT) after treatment in the treatment group were higher than those in the control group, while systolic blood pressure (SBP), diastolic blood pressure (DBP) and low deasity lipoprotein/high density lipoprotein (LDL-C/HDL-C) were lower than those in the control group, the differences were statistically significant (P<0.05). The amount of postpartum hemorrhage in the treatment group was less than that in the control group, and Apgar score in 1 min was higher than that in the control group, the differences were statistically significant (P<0.05). Conclusion Danshen Injection combined with Nicardipine can reduce hypertension of pregnant women, regulate coagulation function and lipid metabolism, protect placental function and improve maternal and infant pregnancy outcomes. 综上所述,在GH的治療过程中应用复方丹参注射液联合尼卡地平取得了良好的效果,对缓解孕妇的血压有很大功效,防止并发症的发生也有帮助。值得在临床治疗中应用。
[参考文献]
[1]Shen M,Smith GN,Rodger M,et al.Comparison of risk factors and outcomes of gestational hypertension and pre-eclampsia[J].PLoS One,2017,12(4):e0175914.
[2]程丽芳,陈云,张焕芳,等.尼卡地平和硝酸甘油用于妊娠期高血压危象的效果[J].广东医学,2016,37(Z1):219-220.
[3]Mitsui T,Masuyama H,Maki J,et al.Differences in uterine arteryblood flow and fetal growth between the early and late onset of pregnancy-induced hypertension[J].J Med Ultrason(2001),2016,43(4):509-517
[4]沈志娟,王冉冉.复方丹参注射液联合间苯三酚治疗妊娠高血压综合征的临床研究[J].现代药物与临床,2017,32(10):1989-1992.
[5]Stanek J.Placental pathology varies in hypertensive conditions of pregnancy[J].Virchows Arch,2018,472(3):415-423.
[6]王丽娟,张同玲,刘伟杰,等.妊娠期高血压应用复方丹参注射液、维生素E及钙剂效果研究[J].河北医药,2016,38(23):3588-3591.
[7]宋娟利.复方丹参注射液联合硫酸镁治疗妊娠高血压疾病及对患者微炎症状态、肾功能的影响[J].陕西中医,2016, 37(4):406-407.
[8]王晓君,王健,李建鄂.芎嗪联合尼卡地平对妊娠高血压患者血压和胎盘血流的影响[J].中国中西医结合杂志,2017, 37(6):671-675.
[9]刘伟杰,张同玲,王丽娟,等.复方丹参注射液联合维生素E及钙剂辅治妊娠期高血压疾病临床观察[J].河北医药,2016,38(20):3124-3127.
[10]卡米拉·合亚斯丁,郝立君,杨丽玮.凝血及纤溶功能联合检测在妊娠高血压综合征患者中的临床价值[J].重庆医学,2016,45(1):607-608.
[11]王坤,张吉仲,李静,等.妊娠高血压合并 OSAHS患者应用CPAP治疗对母儿结果的影响[J].临床耳鼻咽喉头颈外科杂志,2017,31(4):293-294.
[12]蒲文娟,石梅,董明亮,等.丹参注射液联合尼卡地平治疗妊娠期高血压的临床研究[J].现代药物与临床,2018,33(12):3284-3288.
[13]林飞雄.复方丹参注射液治疗妊娠高血压综合征的临床疗效观察[J].吉林医学,2015,8(10):2106.
[14]魏海婷.丹参注射液联合小剂量阿司匹林治疗妊娠高血压的效果观察[J].河南医学研究,2018,27(9):1653-1654.
[15]王迪,王庆军.复方丹参注射液治疗妊娠高血压综合征的临床疗效观察[J].中国实用医药,2014,7(7):162-163.
(收稿日期:2019-02-01 本文编辑:崔建中)
转载注明来源:https://www.xzbu.com/6/view-15026473.htm